Evaluation of copanlisib in combination with eribulin in triple negative breast cancer patient-derived xenograft models.
Guo Z, Luo J, Mashl RJ, Hoog J, Maiti P, Fettig N, Davies SR, Aft R, Held JM, Govindan R, Ding L, Li S, von Morze C, Wulf GM, Shoghi KI, Ma CX.
Guo Z, et al. Among authors: ding l.
Cancer Res Commun. 2024 May 8. doi: 10.1158/2767-9764.CRC-24-0047. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 38717161